Neutralizing Antibodies against SARS-CoV-2 Variants after Infection and Vaccination

Venkata Viswanadh Edara; William H. Hudson; Xuping Xie; Rafi Ahmed; Mehul S. Suthar

doi:10.1001/jama.2021.4388

Neutralizing Antibodies against SARS-CoV-2 Variants after Infection and Vaccination

Venkata Viswanadh Edara
, William H. Hudson
, Xuping Xie
, Rafi Ahmed
, Mehul S. Suthar

Microbiology And Immunology

Research output: Contribution to journal › Letter › peer-review

121 Scopus citations

Original language	English (US)
Pages (from-to)	1896-1898
Number of pages	3
Journal	JAMA - Journal of the American Medical Association
Volume	325
Issue number	18
DOIs	https://doi.org/10.1001/jama.2021.4388
State	Published - May 11 2021

ASJC Scopus subject areas

General Medicine

Access to Document

10.1001/jama.2021.4388

Cite this

@article{7ec429cabba44601b22f4065a08857e2,

title = "Neutralizing Antibodies against SARS-CoV-2 Variants after Infection and Vaccination",

author = "Edara, \{Venkata Viswanadh\} and Hudson, \{William H.\} and Xuping Xie and Rafi Ahmed and Suthar, \{Mehul S.\}",

note = "Funding Information: Funding/Support: This work was supported in part by grants NIH P51 OD011132, 3U19AI057266-17S1 CCHI Immune Memory Supplement, U19AI090023, R01AI127799, R01AI148378, K99AI153736, and UM1AI148684 to Emory University; R00AG049092 and R24AI120942 to the University of Texas Medical Branch from the National Institute of Allergy and Infectious Diseases, National Institutes of Health; the Oliver S. and Jennie R. Donaldson Charitable Trust; the Emory Executive Vice President for Health Affairs Synergy Fund award; the Pediatric Research Alliance Center for Childhood Infections and Vaccines and Children{\textquoteright}s Healthcare of Atlanta; COVID-Catalyst-I3 Funds from the Woodruff Health Sciences Center and Emory School of Medicine; Woodruff Health Sciences Center 2020 COVID-19 CURE Award; and the Vital Projects/ Proteus funds.",

year = "2021",

month = may,

day = "11",

doi = "10.1001/jama.2021.4388",

language = "English (US)",

volume = "325",

pages = "1896--1898",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "18",

}

TY - JOUR

T1 - Neutralizing Antibodies against SARS-CoV-2 Variants after Infection and Vaccination

AU - Edara, Venkata Viswanadh

AU - Hudson, William H.

AU - Xie, Xuping

AU - Ahmed, Rafi

AU - Suthar, Mehul S.

N1 - Funding Information: Funding/Support: This work was supported in part by grants NIH P51 OD011132, 3U19AI057266-17S1 CCHI Immune Memory Supplement, U19AI090023, R01AI127799, R01AI148378, K99AI153736, and UM1AI148684 to Emory University; R00AG049092 and R24AI120942 to the University of Texas Medical Branch from the National Institute of Allergy and Infectious Diseases, National Institutes of Health; the Oliver S. and Jennie R. Donaldson Charitable Trust; the Emory Executive Vice President for Health Affairs Synergy Fund award; the Pediatric Research Alliance Center for Childhood Infections and Vaccines and Children’s Healthcare of Atlanta; COVID-Catalyst-I3 Funds from the Woodruff Health Sciences Center and Emory School of Medicine; Woodruff Health Sciences Center 2020 COVID-19 CURE Award; and the Vital Projects/ Proteus funds.

PY - 2021/5/11

Y1 - 2021/5/11

UR - https://www.scopus.com/pages/publications/85102863077

UR - https://www.scopus.com/pages/publications/85102863077#tab=citedBy

U2 - 10.1001/jama.2021.4388

DO - 10.1001/jama.2021.4388

M3 - Letter

C2 - 33739374

AN - SCOPUS:85102863077

SN - 0098-7484

VL - 325

SP - 1896

EP - 1898

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 18

ER -

Neutralizing Antibodies against SARS-CoV-2 Variants after Infection and Vaccination

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this